GlassScriptPhysician profile
Michael N Megally
NPI 1942549381
$42,854.71
in general payments reported to CMS, 2019-2025
39 companies · $34K in 2025
The $34K reported for 2025 was more than what 97% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $364 · 2020: $1,533 · 2021: $1,639 · 2022: $1,638 · 2023: $1,674 · 2024: $2,146 · 2025: $34K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $29K · Food and Beverage: $7,402 · Travel and Lodging: $804 · Education: $207 · Gift: $17.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $29,250.00 |
| Food and Beverage | $7,401.59 |
| Travel and Lodging | $804.11 |
| Education | $207.11 |
| Gift | $17.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $34,714.81 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,547.42 | 2019-2025 | Ofev, Jascayd, Stiolto Respimat |
| Astrazeneca Pharmaceuticals LP | $1,250.26 | 2020-2025 | Fasenra, Tezspire, Airsupra |
| Philips North America LLC | $699.33 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy, Patient Interface Software |
| Regeneron Healthcare Solutions, INC. | $605.52 | 2022-2025 | Dupixent |
| Genzyme Corporation | $447.98 | 2023-2025 | |
| Grifols USA, LLC | $389.93 | 2021-2025 | Prolastin-C Liquid |
| Verona Pharma, INC. | $305.28 | 2025 | Ohtuvayre |
| Amgen INC. | $247.38 | 2021-2025 | Tezspire |
| Mylan Specialty L.P. | $247.05 | 2019-2024 | Yupelri |
| Harmony Biosciences LLC | $219.29 | 2021-2025 | |
| Baxter Healthcare | $217.96 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Electromed, INC. | $202.49 | 2021-2025 | Smartvest |
| Actelion Pharmaceuticals US, INC. | $185.33 | 2021-2025 | Uptravi, Opsumit |
| Advanced Respiratory, INC | $172.07 | 2020-2021 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $167.10 | 2020-2023 | Cleviprex |
| Inari Medical, INC. | $140.45 | 2022 | |
| Mallinckrodt Hospital Products INC. | $126.49 | 2023-2025 | Acthar |
| Takeda Pharmaceuticals U.S.A., INC. | $112.79 | 2020-2022 | |
| Insmed, INC. | $108.40 | 2024-2025 | Arikayce, Brinsupri |
| Abbvie INC. | $82.21 | 2022-2023 | |
| Inogen, INC. | $60.73 | 2022-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Olympus America INC. | $60.69 | 2019 | |
| Shionogi INC | $59.66 | 2022-2024 | Fetroja |
| Teva Pharmaceuticals USA, INC. | $58.71 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $48.71 | 2024 | Capvaxive |
| Janssen Pharmaceuticals, INC | $43.05 | 2021-2022 | |
| Phadia US INC. | $42.10 | 2022-2024 | Immunocap |
| Jazz Pharmaceuticals INC. | $37.15 | 2020-2024 | |
| 3b Medical, INC. | $35.83 | 2024-2025 | Luna |
| Coaptech, INC. | $31.73 | 2022 | |
| Ani Pharmaceuticals, INC. | $30.75 | 2025 | Purified Cortrophin Gel |
| Vapotherm INC | $29.36 | 2022 | |
| Boston Scientific Corporation | $29.33 | 2020 | |
| Inspire Medical Systems, INC. | $28.60 | 2024 | Inspire |
| Zoll Respicardia, INC. | $20.75 | 2025 | Remede System |
| United Therapeutics Corporation | $16.64 | 2024 | Tyvaso |
| Viatris Specialty LLC | $16.12 | 2025 | Yupelri |
| E.R. Squibb & Sons, L.L.C. | $15.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Megally listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.